Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Managing Pseudomonas aeruginosa respiratory infections in cystic fibrosis

Langan KM, Kotsimbos T, Peleg AY

(2015), Curr Opin Infect Dis, 28(6), 547-56

Bone disease in HIV: recommendations for screening and management in the older patient

Hoy J

(2015), Drugs Aging, 32(7), 549-58

Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial

Harris PN, Peleg AY, Iredell J, Ingram PR, Miyakis S, Stewardson AJ, Rogers BA, McBryde ES, Roberts JA, Lipman J, Athan E, Paul SK, Baker P, Harris-Brown T, Paterson DL

(2015), Trials, 16, 24

Factors influencing antiretroviral adherence and virological outcomes in people living with HIV in the highlands of Papua New Guinea

Gare J, Kelly-Hanku A, Ryan CE, David M, Kaima P, Imara U, Lote N, Crowe SM, Hearps AC

(2015), PLoS One, 10(8), e0134918

The influence of bacterial interaction on the virulence of Cryptococcus neoformans

Dhamgaye S, Murray GL, Peleg AY

(2015), Virulence, 6(7), 677-8

Mycobacterium haemophilum bone and joint infection in HIV/AIDS: case report and literature review

Cross GB, Le Q, Webb B, Jenkin GA, Korman TM, Francis M, Woolley I

(2015), Int J STD AIDS, 26(13), 974-81

Surface coatings with covalently attached caspofungin are effective in eliminating fungal pathogens

Coad BR, Lamont-Friedrich SJ, Gwynne L, Jasieniak M, Griesser S, Traven A, Peleg AY, Griesser HJ

(2015), J Mater Chem B, 43(3), 8469-76

Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

Carr A, Grund B, Neuhaus J, Schwartz A, Bernardino JI, White D, Badel-Faesen S, Avihingsanon A, Ensrud K, Hoy J; International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group

(2015), HIV Med, 16 Suppl 1, 137-46

Economic comparison of an empirical versus diagnostic-driven strategy for treating invasive fungal disease in immunocompromised patients

Barnes R, Earnshaw S, Herbrecht R, Morrissey O, Slavin M, Bow E, McDade C, Charbonneau C, Weinstein D, Kantecki M, Schlamm H, Maertens J

(2015), Clin Ther, 37(6), 1317-1328.e2

An NK cell population lacking FcRγ is expanded in chronically infected HIV patients

Zhou J, Amran FS, Kramski M, Angelovich TA, Elliott J, Hearps AC, Price P, Jaworowski A

(2015), J Immunol, 194(10), 4688-97

Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis

Aldunate M, Srbinovski D, Hearps AC, Latham CF, Ramsland PA, Gugasyan R, Cone RA, Tachedjian G

(2015), Front Physiol, 6, 164

Effects of abacavir administration on structural and functional markers of platelet activation

Trevillyan JM, Arthur JF, Jing J, Andrews RK, Gardiner EE, Hoy JF

(2015), AIDS, 29(17), 2309-13

Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

Wright EJ, Grund B, Cysique LA, Robertson KR, Brew BJ, Collins G, Shlay JC, Winston A, Read TR, Price RW; International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group

(2015), HIV Med, 16 Suppl 1, 97-108

Clinic network collaboration and patient tracing to maximize retention in HIV care

McMahon JH, Moore R, Eu B, Tee BK, Chen M, El-Hayek C, Street A, Woolley I, Buggie A, Collins D, Medland N, Hoy J

(2015), PLoS One, 10(5), e0127726

The HIV care cascade: a systematic review of data sources, methodology and comparability

Medland NA, McMahon JH, Chow EP, Elliott JH, Hoy JF, Fairley CK

(2015), J Int AIDS Soc, 18, 20634

Why are we not screening for anal cancer routinely - HIV physicians' perspectives on anal cancer and its screening in HIV-positive men who have sex with men: a qualitative study

Ong JJ, Temple-Smith M, Chen M, Walker S, Grulich A, Hoy J, Fairley CK

(2015), BMC Public Health, 15, 67

The prevalence and impact of antimicrobial allergies and adverse drug reactions at an Australian tertiary centre

Trubiano JA, Cairns KA, Evans JA, Ding A, Nguyen T, Dooley MJ, Cheng AC

(2015), BMC Infect Dis, 15, 572

Draft genome sequences of clinical daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus strain APS211 and its daptomycin-susceptible progenitor APS210

Cameron DR, Jiang JH, Abbott IJ, Spelman DW, Peleg AY

(2015), Genome Announc, 3(3), e00568-15

Changes in the prevalence of lipodystrophy, metabolic syndrome and cardiovascular disease risk in HIV-infected men

Price J, Hoy J, Ridley E, Nyulasi I, Paul E, Woolley I

(2015), Sex Health, 12(3), 240-8

Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta-analysis

Heng SC, Morrissey O, Chen SC, Thursky K, Manser RL, Nation RL, Kong DC, Slavin M

(2015), Crit Rev Microbiol, 41(1), 124-34

26 27 28 29 30